(Q40596325)

English

A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia

scientific article published on 14 September 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

0 references

multicenter clinical trial

0 references

placebo-controlled trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A Del Favero

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

F Menichetti

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

P Martino

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

G Bucaneve

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

A Micozzi

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

G Gentile

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

P Furno

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

D Russo

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

D D'Antonio

9

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

P Ricci

10

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

B Martino

11

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

F Mandelli

12

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Infection Program

13

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

14 September 2001

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1295-1301

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1086%2F322646

21 January 2018

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

https://api.crossref.org/works/10.1086%2F322646

21 January 2018

Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group

1 reference

https://api.crossref.org/works/10.1086%2F322646

21 January 2018

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Tre

1 reference

https://api.crossref.org/works/10.1086%2F322646

21 January 2018

A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients

1 reference

https://api.crossref.org/works/10.1086%2F322646

21 January 2018

A Comparison of Imipenem to Ceftazidime With or Without Amikacin as Empiric Therapy in Febrile Neutropenic Patients

1 reference

https://api.crossref.org/works/10.1086%2F322646

21 January 2018

Amikacin serum concentrations: prediction of levels and dosage guidelines

1 reference

https://api.crossref.org/works/10.1086%2F322646

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40596325&oldid=1903503420"